Health Care & Life Sciences » Pharmaceuticals | China Shineway Pharmaceutical Group Ltd.

China Shineway Pharmaceutical Group Ltd. | Mutual Funds

Mutual Funds that own China Shineway Pharmaceutical Group Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Skagen Kon Tiki
22,953,000
2.78%
-3,540,000
1.31%
06/30/2018
Government Pension Fund - Global (The)
11,357,963
1.37%
578,939
0%
12/31/2017
Vanguard Total International Stock Index Fund
4,167,000
0.5%
0
0%
07/31/2018
4,108,000
0.5%
4,108,000
0.48%
03/31/2018
Vanguard Emerging Markets Stock Index Fund
4,002,000
0.48%
-70,000
0.01%
07/31/2018
iShares Core MSCI Emerging Markets ETF
3,937,000
0.48%
0
0.01%
09/05/2018
DFA Emerging Markets Small Cap Series
2,378,200
0.28%
0
0.05%
01/31/2018
WisdomTree Emerging Markets Small Cap Dividend Fund
2,122,000
0.26%
0
0.21%
09/06/2018
DFA Emerging Markets Core Equity Portfolio
1,999,000
0.24%
104,000
0.01%
04/30/2018
1,821,000
0.22%
139,000
0.37%
06/29/2018

About China Shineway Pharmaceutical Group

View Profile
Address
Luan Cheng
Shijiazhuang Hebei 051430
China
Employees -
Website http://www.shineway.com
Updated 07/08/2019
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. Its products include Shen Mai injection, Qing Kai Ling injection, and Wu Fu Xin Nao Qing soft capsule. The company was founded by Zhen Jiang Li and Yun Xia Xin on August 14, 2002 and is headquartered in Shijiazhuang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.